Patents by Inventor Patanjali RAVVA

Patanjali RAVVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD40 ANTIBODIES FOR USE IN TREATING AUTOIMMUNE DISEASE
    Publication number: 20240309105
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: December 18, 2023
    Publication date: September 19, 2024
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Juergen Theodor STEFFGEN, David P. JOSEPH, James HILBERT, Patanjali RAVVA
  • ANTI-CD40 ANTIBODIES FOR USE IN TREATING AUTOIMMUNE DISEASE
    Publication number: 20210261678
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: June 28, 2019
    Publication date: August 26, 2021
    Inventors: Juergen Theodor STEFFGEN, David P. JOSEPH, James HILBERT, Patanjali RAVVA